How Bacterial Pumps and Membranes Help Resist Antibiotics

Jenn Hoskins
13th April, 2025

How Bacterial Pumps and Membranes Help Resist Antibiotics

Validating the results of a genetic screen, the targeted knockdown of several membrane transporter genes significantly increased the susceptibility of Mycobacterium abscessus to linezolid, as demonstrated by reduced bacterial proliferation (a, b) and lower drug concentrations required for inhibition (cā€“i).

Image adapted from: McGowen et al. / CC BY (Source)

Key Findings

  • *Harvard researchers found that antibiotics struggle to enter M. abscessus, a tough bacteria causing lung infections.*
  • *They discovered specific proteins that pump these drugs out, reducing their effectiveness against the bacteria.*
  • *Targeting these proteins could boost antibiotic success, offering better treatments for resistant infections.*
Antibiotic resistance in bacterial pathogens poses a significant challenge to public health, particularly with organisms like Mycobacterium abscessus. This bacterium is known to cause severe lung infections and exhibits intrinsic resistance to many antibiotics, making infections difficult to treat. Understanding the mechanisms behind this resistance is crucial for developing effective treatments. A recent study conducted by researchers at the Harvard T.H. Chan School of Public Health[1] sheds light on how M. abscessus withstands antibiotic attacks. The study focused on the accumulation of antibiotics within the bacterial cells, a key factor that determines the effectiveness of these drugs. Using mass spectrometry, the researchers measured how different antibiotics penetrate M. abscessus cells and found significant variability in drug accumulation. Notably, the antibiotic linezolid was found to accumulate poorly within the bacteria, suggesting that its limited uptake reduces its efficacy against M. abscessus infections. To delve deeper into why linezolid fails to accumulate effectively, the research team employed a technique called transposon mutagenesis screening. This method involves creating random mutations in the bacterial genome to identify genes that contribute to antibiotic resistance. Through this screening, the team identified several transporter proteins that play a role in either allowing antibiotics to enter the bacterial cell or actively pumping them out. Among these, an uncharacterized protein was discovered to efflux linezolid and several related antibiotics, further explaining the low accumulation levels observed. The findings confirm that membrane permeability and drug efflux are critical mechanisms by which M. abscessus resists antibiotic treatment. This aligns with previous research that highlighted the importance of the mycobacterial cell wall in antibiotic resistance. Studies have shown that the unique structure of the mycobacterial cell wall[2] limits the entry of hydrophilic antibiotics and slows down the diffusion of lipophilic agents. Additionally, enzymatic inactivation of drugs, as seen with tetracycline resistance in M. abscessus[3], contributes to the bacterium's ability to survive antibiotic assaults. Furthermore, the research builds on the understanding of mycobacterial transport systems described in earlier reviews[4]. These transporters are essential for maintaining the complex cell envelope of mycobacteria, which acts as a formidable barrier against external threats, including antibiotics. By identifying specific transporters involved in drug efflux, the study provides targets for potential therapies that could inhibit these proteins and enhance antibiotic accumulation within the bacteria. The implications of this study are significant for the treatment of infections caused by M. abscessus. By demonstrating that targeting membrane transporters can increase the effectiveness of certain antibiotics, the research opens the door to combination therapies that overcome existing resistance mechanisms. This approach is supported by findings in tuberculosis research, where inhibiting efflux pumps has been proposed as a strategy to potentiate antibiotic efficacy against Mycobacterium tuberculosis[5]. In practical terms, the study suggests that developing drugs to block these transporters could make antibiotics like linezolid more effective against M. abscessus. Such advancements are crucial, given the high level of resistance this pathogen exhibits compared to other mycobacteria like Mycobacterium smegmatis and Mycobacterium tuberculosis[3]. By addressing both membrane permeability and drug efflux, new treatment strategies can be formulated to combat these resilient bacterial infections more effectively. Overall, the research from Harvard underscores the importance of understanding bacterial resistance at the molecular level. By identifying and targeting the specific mechanisms that M. abscessus uses to evade antibiotics, scientists are one step closer to developing more effective treatments for difficult-to-treat infections. This study not only enhances our comprehension of antibiotic resistance in mycobacteria but also paves the way for innovative approaches to overcoming this formidable challenge.

MedicineBiotechBiochem

References

Main Study

1) Efflux pumps and membrane permeability contribute to intrinsic antibiotic resistance in Mycobacterium abscessus

Published 10th April, 2025

https://doi.org/10.1371/journal.ppat.1013027

Related Studies

2) Mycobacterial cell wall: structure and role in natural resistance to antibiotics.

Journal: FEMS microbiology letters, Issue: Vol 123, Issue 1-2, Oct 1994

3) High Levels of Intrinsic Tetracycline Resistance in Mycobacterium abscessus Are Conferred by a Tetracycline-Modifying Monooxygenase.

https://doi.org/10.1128/AAC.00119-18

4) Transporters Involved in the Biogenesis and Functionalization of the Mycobacterial Cell Envelope.

https://doi.org/10.1021/acs.chemrev.0c00869

5) Efflux pumps in Mycobacterium tuberculosis and their inhibition to tackle antimicrobial resistance.

https://doi.org/10.1016/j.tim.2021.05.001


Related Articles

An unhandled error has occurred. Reload šŸ—™